North Carolina-based 9 Meters Biopharma, a clinical-stage company that creates treatments for digestive diseases, is discontinuing its Phase III trial studying larazotide for the treatment of celiac disease due to disappointing interim results.
https://www.pharmalive.com/wp-content/uploads/2022/06/BioSpaceCeliacdisease6-21-2022.jpg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-06-21 08:00:472022-06-21 12:13:52Disappointing results end 9 Meters' Phase III trial for celiac treatment
